The Uromigos
The Uromigos
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 37: Regoratinib (FGFR inhibitor) and Atezolizumab in UC with Jonathan Rosenberg
18 minutes
Posted Jun 1, 2020 at 10:44 am.
0:00
18:11
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Everything you wanted to know about FGFR inhibition but were afraid to ask.
Previous
Episode 36: Dr. Tian Zhang discusses three ASCO bladder cancer abstracts with immune therapy/targeted therapy combinations
Next
Episode 38: The Uromigos Virtual World Tour - starting in Vancouver with Atezolizumab in NMIBC
← See all 501 episodes of The Uromigos